This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raoult, D
Right arrow Articles by Baca, O G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raoult, D
Right arrow Articles by Baca, O G

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1989 May; 33(5): 621-623

Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells.

D Raoult, M R Yeaman and O G Baca

Centre National de Reference des Rickettsioses, Groupe Hospitalier de la Timone, Marseilles, France.

ABSTRACT

The relative lack of efficacy of the antibiotic treatment of chronic Q fever endocarditis justifies the further evaluation of the susceptibility of Coxiella burnetii to the modern quinolone antibiotics. We evaluated the efficacies of pefloxacin and ofloxacin in controlling the Nine Mile isolate of C. burnetii by using an embryonated egg assay and persistently infected L929 cells in culture. Pefloxacin was effective in controlling the intracellular parasite at a concentration of 50 micrograms per egg and 1 microgram/ml in cultures of infected cells. Ofloxacin was effective at a concentration of 25 micrograms per egg and 0.5 microgram/ml in infected-cell cultures. In light of the fact that the concentrations of antibiotics used fall within physiological ranges used in humans, ofloxacin and pefloxacin may be useful in the clinical management of chronic Q fever, for which, to date, results have been poor.


Antimicrob Agents Chemother. 1989 May; 33(5): 621-623




This article has been cited by other articles:

  • CONE, L. A., CURRY, N., SHAVER, P., BROOKS, D., DEFORGE, J., POTTS, B. E. (2006). Q Fever in the southern california desert: epidemiology, clinical presentation and treatment.. Am J Trop Med Hyg 75: 29-32 [Abstract] [Full Text]  
  • Maurin, M., Raoult, D. (1999). Q Fever. Clin. Microbiol. Rev. 12: 518-553 [Abstract] [Full Text]